TheraRadar
← Back
Data updated: Mar 29, 2026

ORBION PHARMS

NeurologyImmunology
Generics

ORBION PHARMS is a generic drug manufacturer focused on Neurology, Immunology.

2007
Since
27
Drugs
-
Trials
407
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

ARIPIPRAZOLE 2026-02-18
AMLODIPINE BESYLATE 2026-02-17
Manufacturing (CMC)
OLANZAPINE 2026-02-09
Labeling
OLANZAPINE 2026-02-09
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 50%
2 drugs
Immunology 50%
0 drugs Phase 3: 2 Phase 2: 2

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

AbbVie big-pharma
Immunology, Neurology
GSK big-pharma
Immunology, Neurology
Eli Lilly big-pharma
Immunology, Neurology
Roche big-pharma
Neurology, Immunology
Bristol-Myers Squibb big-pharma
Immunology, Neurology